Related Experiment Videos
Cell kinetics of solid tumors with time and its clinical implication.
R Silvestrini1, M G Daidone, A Costa
1Oncologia Sperimentale C, Istituto Nazionale Tumori, Milan, Italy.
Tumori
|August 31, 1989
Summary
Tumor cell proliferation rate, measured by S-phase fraction, predicts cancer patient outcomes. Higher proliferation indicates greater aggressiveness and potential for metastasis, influencing treatment strategies and survival rates.
Area of Science:
- Oncology
- Cell Biology
- Cancer Research
Background:
- Tumor proliferative rate, assessed as S-phase fraction, is a key biological marker.
- Traditional prognostic factors may be less informative than cell kinetics.
Purpose of the Study:
- To evaluate the prognostic significance of tumor proliferative rates in various human cancers.
- To correlate proliferation indices with clinical evolution, metastatic potential, and treatment response.
Main Methods:
- Autoradiographic determination of 3H-thymidine incorporation.
- Flow cytometric evaluation of DNA content to determine S-phase fraction.
Main Results:
- Proliferative rate is not linked to pathologic stage but predicts clinical evolution and survival.
- In early-stage disease, proliferation predicts relapse-free and overall survival, and metastatic potential.
- In advanced disease, proliferation influences survival and indicates aggressiveness and chemosensitivity in responsive tumors.
- Metastatic lesions show increased proliferation compared to primary tumors, indicating disease progression.
Conclusions:
- Tumor cell proliferation rate is a significant prognostic indicator across different cancer stages.
- Understanding proliferation kinetics can guide therapeutic decisions and predict treatment outcomes.
- Increased proliferation in metastatic lesions highlights its role in disease progression.